Katja Issbrücker

1.5k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

Katja Issbrücker is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katja Issbrücker has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katja Issbrücker's work include Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Antimicrobial Peptides and Activities (2 papers). Katja Issbrücker is often cited by papers focused on Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Antimicrobial Peptides and Activities (2 papers). Katja Issbrücker collaborates with scholars based in Germany, United States and Netherlands. Katja Issbrücker's co-authors include Matthias Clauss, Peter Boekstegers, Corinna Lebherz, Stefan Zahler, Claus Vogelmeier, Achim Pfosser, Pieter S. Hiemstra, Mohamed Zaiou, Pia Unterberger and Richard L. Gallo and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Katja Issbrücker

8 papers receiving 1.2k citations

Hit Papers

An angiogenic role for the human peptide antibiotic LL-37... 2003 2026 2010 2018 2003 200 400 600

Peers

Katja Issbrücker
Xiuju Dai Japan
Mieke Bergers Netherlands
Paul F. Kotol United States
Monica Ruse United States
Lyudmila Lyakh United States
Katja Issbrücker
Citations per year, relative to Katja Issbrücker Katja Issbrücker (= 1×) peers Achim Pfosser

Countries citing papers authored by Katja Issbrücker

Since Specialization
Citations

This map shows the geographic impact of Katja Issbrücker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Issbrücker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Issbrücker more than expected).

Fields of papers citing papers by Katja Issbrücker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Issbrücker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Issbrücker. The network helps show where Katja Issbrücker may publish in the future.

Co-authorship network of co-authors of Katja Issbrücker

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Issbrücker. A scholar is included among the top collaborators of Katja Issbrücker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Issbrücker. Katja Issbrücker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Koczulla, Andreas Rembert, Georges von Degenfeld, Christian Kupatt, et al.. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. Journal of Clinical Investigation. 111(11). 1665–1672. 36 indexed citations
2.
Koczulla, Andreas Rembert, Georges von Degenfeld, Christian Kupatt, et al.. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. Journal of Clinical Investigation. 111(11). 1665–1672. 699 indexed citations breakdown →
3.
Lucerna, Markus, Diana Mechtcheriakova, Alexandra Kadl, et al.. (2003). NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells. Journal of Biological Chemistry. 278(13). 11433–11440. 87 indexed citations
4.
Clauss, Matthias, Frederic Pipp, Katja Issbrücker, et al.. (2003). Dissection of Monocyte and Endothelial Activities by Using VEGF-Receptor Specific Ligands. Advances in experimental medicine and biology. 522. 75–82. 7 indexed citations
5.
Heil, Matthias, Katja Issbrücker, Joop van den Heuvel, et al.. (2003). An Engineered Heparin-Binding Form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells. Angiogenesis. 6(3). 201–211. 16 indexed citations
6.
Pipp, Frederic, Matthias Heil, Katja Issbrücker, et al.. (2003). VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic. Circulation Research. 92(4). 378–385. 255 indexed citations
7.
Issbrücker, Katja, Hugo H. Marti, Stefan Hippenstiel, et al.. (2002). p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability. The FASEB Journal. 17(2). 262–264. 143 indexed citations
8.
Blum, Sabine, Katja Issbrücker, Antje Willuweit, et al.. (2001). An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression.. Journal of Biological Chemistry. 276(45). 42618–42618. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026